News
-
Bayer Unveils New Packaging Lines At Myerstown PA Manufacturing Facility Following $44 Million Investment
4/22/2025
Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer’s commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community.
-
Exterro Disrupts The Status Quo For Mobile Device Investigations
2/18/2025
Exterro, Inc., the leading provider of data risk management software solutions for e-discovery, digital forensics, and data privacy, security, and governance professionals, today announced its latest industry-shaping innovation – Exterro Remote Mobile Discovery.
-
AmpliTech's Cryogenic LNAs Power The Future Of Quantum Computing And AI
7/15/2025
AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the critical role its cryogenic Low Noise Amplifiers (LNAs) are playing in enabling the next generation of quantum computing—technology that is rapidly evolving to overcome the limitations of traditional silicon-based computing and fueling the rise of AI beyond classical boundaries.
-
Batavia Biosciences Partners With VBC And MEVAC To Advance Localized Vaccine Manufacturing In Egypt
3/13/2025
Batavia Biosciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in development and manufacturing of vaccines and viral vectors, is excited to announce a strategic collaboration with Vaccine Biotechnology City (VBC) and MEVAC, two pioneering organizations in Egypt.
-
AT&T To Acquire Spectrum Licenses From EchoStar
8/26/2025
AT&T (the Company) has agreed to purchase certain wireless spectrum licenses from EchoStar for a total of approximately $23b, subject to certain adjustments.
-
REGENESIS' IBIS Awarded 2024 EBJ Business Achievement Technology Merit Award
2/12/2025
Environmental Business Journal® (EBJ), an independent business research publication that has provided strategic market intelligence to the environmental industry since 1988, has honored REGENESIS with the Business Achievement Award for Technology Merit in 2024.
-
FF-10832 Granted FDA Orphan Drug Designation For The Treatment Of Biliary Tract Cancer
7/7/2025
FUJIFILM Pharmaceuticals U.S.A., Inc., drug development center and a leading provider of Contract Development and Manufacturing Organization (CDMO) services for drug delivery system (DDS) technologies, today announced that the U.S.
-
Trident IoT Unveils Revolutionary Software Development Kits For Z-Wave/ZWLR And Zigbee RF SoCs
4/2/2025
Trident IoT is proud to announce the release of its highly anticipated Software Development Kits (SDKs) for its latest line of Z-Wave/ZWLR and Zigbee RF System-on-Chips (SoCs).
-
Kraig Biocraft Laboratories Successfully Completes Lab-To-Field Transition For Three New Spider Silk Production Strains
7/21/2025
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the successful completion of the first rearing cycles for its three newest recombinant spider silk production strains.
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test
6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).